MDwise is focusing on medication by adding Medication Therapy Management Part D functionality in the Jiva population health platform from ZeOmega.
The move means the 1,400-plus providers in MDwise's network can now access Jiva to better understand the medications patients are being prescribed, assess their drug therapy adherence, and make necessary adjustments to improve medication safety.
This is especially important for more than 360,000 elderly, low-income, youth, and other vulnerable populations served by MDwise plans such as Hoosier Healthwise, Healthy Indiana Plan, and Hoosier Care Connect.
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Amgen announces Q1 2026 dividend
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera